Today: 20 May 2026
Oklo stock jumps nearly 15% as DOE backs uranium enrichment — what’s next for OKLO
6 January 2026
1 min read

Oklo stock jumps nearly 15% as DOE backs uranium enrichment — what’s next for OKLO

New York, January 5, 2026, 19:30 EST — After-hours

  • Oklo shares closed up 14.8% on Monday, holding steady in late trading.
  • The move tracked a rally in nuclear-linked names after the U.S. Energy Department announced $2.7 billion in uranium-enrichment awards.
  • Traders are watching follow-on federal fuel awards and Friday’s U.S. jobs report.

Oklo Inc. shares rose 14.8% on Monday and were little changed in after-hours trading, as investors piled into advanced nuclear names after the U.S. Energy Department moved to expand domestic uranium enrichment. The stock closed at $89.34.

The federal awards target high-assay low-enriched uranium, or HALEU — fuel enriched beyond the level used in most of today’s reactors — as well as standard low-enriched uranium, the department said. HALEU is uranium enriched between 5% and 20%, compared with about 5% for conventional reactor fuel.

Why it matters now: fuel supply has become a constraint for many next-generation reactor designs and small modular reactors — a catch-all term for smaller units pitched as faster to deploy. Oklo has warned investors that its “powerhouses” are expected to rely on HALEU and that difficulty accessing HALEU or recycled fuel could hit its ability to manufacture fuel and produce power, a filing showed. SEC filing

The Energy Department said it awarded orders totaling $2.7 billion over 10 years to American Centrifuge Operating, General Matter and Orano Federal Services, with the contracts tied to milestones for enrichment services. It also awarded $28 million to Global Laser Enrichment, part-owned by Canadian uranium producer Cameco, to further its work on enrichment technology, the Reuters report said.

Nuclear-linked stocks broadly advanced alongside Oklo. NuScale Power gained about 15% and Nano Nuclear Energy rose about 12%, while the Global X Uranium ETF added roughly 5.6%.

Some analysts cautioned the initial award size fell short of earlier expectations. Evercore ISI analyst Nicholas Amicucci said the amount looked “slightly underwhelming relative to consensus expectations,” and flagged roughly $700 million in additional DOE awards for HALEU production that he said still appears unallocated, according to Investing.com. Investing.com

The fuel angle matters for Oklo because federal support can reduce one layer of execution risk for companies that still need to move from design and licensing milestones to construction and delivery. The Energy Department noted Russia is currently the only country producing HALEU in commercial volumes, and U.S. funding to build domestic supply was included in a law that bans Russian uranium shipments fully by 2028.

But the enrichment build-out will take time and depends on contractors meeting milestones, and critics of HALEU argue it poses proliferation risk if it falls into the wrong hands. For Oklo, investors also face the familiar downside scenario for early-stage nuclear developers: setbacks in licensing, fuel availability or project financing can quickly reset timelines and valuations.

Next up, traders will watch for details and timing around DOE task orders and any additional HALEU awards — and for a broader risk check on Friday, when the Bureau of Labor Statistics releases the December employment report at 8:30 a.m. ET.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Tesla stock rebounds after seven-session slide as investors refocus on earnings
Previous Story

Tesla stock rebounds after seven-session slide as investors refocus on earnings

Marvell (MRVL) stock lifts on Melius “buy” call, with CES CEO appearance next
Next Story

Marvell (MRVL) stock lifts on Melius “buy” call, with CES CEO appearance next

Go toTop